2025.09.19
From September 14th to 17th, 2025, the 59th European Congress of Toxicology (EUROTOX 2025) was grandly held in Athens, Greece. Milecell Biotechnology and its subsidiary Kryogene™ made a remarkable appearance at the event, marking a significant international debut with their self-developed in vitro hepatocyte models and high-performance cell freezing media series.
Milecell’s booth attracted numerous international experts and scholars, fostering extensive discussions on potential collaborations. During the congress, Dr. Binlu Huang, Chief Scientific Officer (CSO) of Milecell Biotechnology, presented a poster titled "Primary cell-based 3D models for toxicity test and disease modeling". The presentation systematically demonstrated the application of primary cell-based 3D models in toxicology testing and disease modeling, facilitating in-depth academic exchanges with global peers.
This participation not only garnered international academic attention for Milecell Bio’s innovative products and technological achievements but also significantly enhanced the company's brand influence within the global biopharmaceutical sector. It has laid a solid foundation for future global expansion and deeper engagement in the international market.
Keywords: self-developed in vitro hepatocyte models, cell freezing media series, Milecell Biotechnology, Kryogene™
